Questa Capital Management, a Washington, DC and San Francisco, CA-based venture growth equity firm dedicated to the healthcare industry, closed Questa Capital Partners II, LP, with $348m of capital commitments.
The firm’s second fund was oversubscribed at its hard cap, securing commitments from a diversified blue-chip investor base comprised of leading endowments, foundations, family offices, consultants, pension plans and fund-of-funds. It will invest selectively in later stage companies in healthcare services, technology and medical devices with significant growth potential.
Led by Founder and Managing Partner Ryan Drant, Questa Capital is an active and collaborative partner for the companies in which it invests. The team brings deep sector expertise in healthcare services, technology and medical devices, and a deep network and industry experience to help guide portfolio companies toward leading market positions and accelerated growth. Current and exited companies within the Questa portfolio include Dispatch Health, EPIX Therapeutics (acquired by Medtronic in early 2019), and Medrio among others.
Questa closed its inaugural fund in 2018 with $199 million of capital commitments.
The team also includes industry veterans Brad Sloan and Shawn Conway.